These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38554098)

  • 21. Academic collaborations with industry: lessons for the future.
    Reddy SSK; Chao S
    J Investig Med; 2020 Dec; 68(8):1305-1308. PubMed ID: 33168581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chapter 1. A contemporary history of the Japanese pharmaceutical industry (1980-2010). A contemporary history of the Japanese Pharmaceutical Industry (1980-2010) Task Force].
    Yakushigaku Zasshi; 2014; 49(1):18-38. PubMed ID: 25272635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Industry-Academia Partnership: The Synthesis and Solid-State Pharmaceutical Centre (SSPC) as a Collaborative Approach from Molecule to Medicine.
    McGlacken GP; Hayes S; Maguire AR; O'Halloran J; Hodnett K
    Chemistry; 2018 Jan; 24(2):499-503. PubMed ID: 29235704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy crisis in the spotlight--is open collaboration between academia and industry the answer?
    Kaski JC
    Cardiovasc Drugs Ther; 2011 Apr; 25(2):187-8. PubMed ID: 21503624
    [No Abstract]   [Full Text] [Related]  

  • 26. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing novel therapies for neurodegeneration through an innovative model for industry-academia collaborations: A decade of the Eisai-UCL experience.
    Atkinson PJ; Swami M; Ridgway N; Roberts M; Kinghorn J; Warner TT; Staddon JM; Takle AK
    Drug Discov Today; 2023 Oct; 28(10):103732. PubMed ID: 37541423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are academic drug discovery efforts receiving more recognition with declining industry efficiency?
    Bryans JS; Kettleborough CA; Solari R
    Expert Opin Drug Discov; 2019 Jul; 14(7):605-607. PubMed ID: 30907161
    [No Abstract]   [Full Text] [Related]  

  • 29. Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective.
    Williams RJ; Walker I; Takle AK
    Drug Discov Today; 2012 Mar; 17(5-6):185-7. PubMed ID: 22314099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug discovery: new models for industry-academic partnerships.
    Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
    Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three researchers developing therapies based on RNA interference talk about their experiences leaving academia for biotech companies.
    Bonetta L
    Biotechniques; 2007 Apr; 42(4 Suppl):S10-11, S16. PubMed ID: 18798733
    [No Abstract]   [Full Text] [Related]  

  • 32. Collaboration between academia and pharma to bring new therapies to market more important than ever.
    Caffrey MK
    Am J Manag Care; 2014 Feb; 20(2 Spec No.):E14. PubMed ID: 25764579
    [No Abstract]   [Full Text] [Related]  

  • 33. Linking academia and industry to bring drugs to the clinic: an interview with George Tidmarsh.
    Tidmarsh G
    Dis Model Mech; 2013 Jul; 6(4):874-6. PubMed ID: 23828643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helping science and drug development to succeed through pharma-academia partnerships: Yale Healthcare Conference 2013.
    Yang DX; Kim YA
    Yale J Biol Med; 2013 Sep; 86(3):429-32. PubMed ID: 24058318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Places of pharmaceutical knowledge-making: global health, postcolonial science, and hope in South African drug discovery.
    Pollock A
    Soc Stud Sci; 2014 Dec; 44(6):848-73. PubMed ID: 25608441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Consideration on Academia Environments for Creating Medical Innovation].
    Iida K; Ishida T; Nishimura N
    Yakugaku Zasshi; 2022 Jan; 142(1):75-84. PubMed ID: 34629350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The path to producing pharmaceuticals from natural products uncovered by academia-from the perspective of a science coordinator.
    Fujie A
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):38-42. PubMed ID: 27885934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The critical path initiative: leveraging collaborations to enhance regulatory science.
    Barratt RA; Bowens SL; McCune SK; Johannessen JN; Buckman SY
    Clin Pharmacol Ther; 2012 Mar; 91(3):380-3. PubMed ID: 22343813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. University - industry collaborations: models, drivers and cultures.
    Ehrismann D; Patel D
    Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.